2-bromolysergic acid diethylamide (BOL)

was heading 1975-94 (see under LYSERGIC ACID DIETHYLAMIDE 1975-90); BROMO-LSD was see 2-BROMOLYSERGIC ACID DIETHYLAMIDE 1975-94; use LYSERGIC ACID DIETHYLAMIDE to search 2-BROMOLYSERGIC ACID DIETHYLAMIDE 1975-94; a serotonin antagonist

Also Known As:

Networked: 52 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Azzali, Silvia: 3 articles (01/2021 - 04/2020)
2.	Garlassi, Sara: 3 articles (01/2021 - 04/2020)
3.	Paterlini, Federica: 3 articles (01/2021 - 04/2020)
4.	Pelizza, Lorenzo: 3 articles (01/2021 - 04/2020)
5.	Poletti, Michele: 3 articles (01/2021 - 04/2020)
6.	Pupo, Simona: 3 articles (01/2021 - 04/2020)
7.	Raballo, Andrea: 3 articles (01/2021 - 04/2020)
8.	Scazza, Ilaria: 3 articles (01/2021 - 04/2020)
9.	Chiri, Luigi Rocco: 2 articles (01/2021 - 08/2020)
10.	Tousson, Ehab: 2 articles (02/2016 - 01/2016)

Related Diseases

1.	Poliomyelitis (Polio) 04/15/2021 - "The study was based on review of call records during polio supplemental immunization campaigns in Bol Districts in Chad from February to May 2018. " 05/01/1960 - "[The treatment of respiratory disorders in acute poliomyelitis from data of the Gor'kovskaia gorodskaia detskaia klinicheskaia bol'nitsa]."
2.	Myocardial Infarction 03/01/1975 - "Two cases, a sixteen-month-old girl and a 13 year-old bol, were presented who developed myocardial infarction as a consequence of angiocardiographic study. " 04/01/1994 - "Procedural success was achieved in 39 (93%) BOL; the only major complication was a periprocedural myocardial infarction (CPKMB=58IU/ml). "
3.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/2023 - "While we cannot draw causal inferences due to the retrospective, nonrandomized study design, these data suggest that replacing BOL with prolonged CIV administration has not been effective as a strategy to mitigate cardiac events, given community standards of oncologic practice." 01/01/2023 - "Administration of doxorubicin by continuous intravenous (CIV) infusion, versus bolus (BOL) administration, has been proposed to mitigate the risk of cardiac events. " 01/01/2023 - "Occurrence of cardiac events after initiation of BOL versus CIV doxorubicin for sarcoma in the International Business Machines MarketScan claims database were compared. "
4.	Neoplasms (Cancer) 01/01/2023 - "Herein, potent tumor growth suppression (>80%) and STAT3 inhibition was observed in two different mouse models following BOL administration. " 01/01/2023 - "The Beads of Life (BOL) approach uses a narratively informed methodology 'to enable children and young people to make sense of their cancer journey in ways that make them stronger'. " 08/01/2019 - "The average tumor thickness was 23 mm (24 mm in mOL, 20 mm in bOL). " 01/01/2019 - "Administration of 4 mg/kg BOL significantly inhibited CRC tumor xenografts [p < 0.001], but no effect was observed in a STAT3-/- tumor model. " 08/01/2017 - "rubra (BOL) against HT-1080 cancer cells and bacterial cells as well as their wound healing efficacy using a mouse model. "
5.	Death (Near-Death Experience) 01/01/2018 - "Complete degradation analyses of the solar panel have been done to ensure that it will meet the satellite power requirements at BOL (beginning of life) and EOL (end of life). " 03/21/2017 - "In order to assess the electro-catalysts stability, accelerated degradation tests were carried out by cycling the cell potential between 0.6 V and 1.2 V. By comparing the electrochemical and physico-chemical parameters at the beginning of life (BoL) and end of life (EoL), it was demonstrated that the Pt₁Ni₁/C catalyst was the most stable among the catalyst series, with only a 2% loss of voltage at 200 mA·cm-2 and 12.5% at 950 mA·cm-2. " 06/04/2020 - "The mass activity at BOL only dropped by 24% after 30 000 voltage cycles at end-of-life (EOL) in a metal dissolution accelerated stress test. " 01/08/2015 - "Data are obtained at the initial beginning of life (BOL, ~200 voltage cycles) and after 10k and 30k (end of life, EOL) voltage cycles following DOE protocol (0.6-1.0 V vs reversible hydrogen electrode). "

Related Drugs and Biologics

1.	2-bromolysergic acid diethylamide (BOL)
2.	Polytetrafluoroethylene (Teflon)
3.	Methysergide (Sansert)
4.	Doxorubicin (Adriamycin)
5.	Antipyretics
6.	Chitosan
7.	Type 1 Angiotensin Receptor
8.	cdc25 Phosphatases
9.	Steroids
10.	Solutions

Related Therapies and Procedures

1.	Intramuscular Injections
2.	Mud Therapy (Mud Bath)
3.	Intravenous Infusions
4.	Immunotherapy
5.	Renal Dialysis (Hemodialysis)